Abcuro announces pre-clinical data on new immuno-oncology target
Member News
First in vivo validation of KLRG1 as a new cancer immunotherapy target
Related or similar articles
April 29, 2024
Lab Space Boston: Navigating Opportunities and Challenges
Hello, fellow science enthusiasts! If you're on the hunt for the perfect laboratory space in greater Boston and Cambridge, you've come to the right place. As experts in the field, we at Labshares know a thing or two about navigating the opportunities
Labshares News